379 related articles for article (PubMed ID: 34741815)
1. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.
Mohile SG; Mohamed MR; Xu H; Culakova E; Loh KP; Magnuson A; Flannery MA; Obrecht S; Gilmore N; Ramsdale E; Dunne RF; Wildes T; Plumb S; Patil A; Wells M; Lowenstein L; Janelsins M; Mustian K; Hopkins JO; Berenberg J; Anthony N; Dale W
Lancet; 2021 Nov; 398(10314):1894-1904. PubMed ID: 34741815
[TBL] [Abstract][Full Text] [Related]
2. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.
Mohile SG; Epstein RM; Hurria A; Heckler CE; Canin B; Culakova E; Duberstein P; Gilmore N; Xu H; Plumb S; Wells M; Lowenstein LM; Flannery MA; Janelsins M; Magnuson A; Loh KP; Kleckner AS; Mustian KM; Hopkins JO; Liu JJ; Geer J; Gorawara-Bhat R; Morrow GR; Dale W
JAMA Oncol; 2020 Feb; 6(2):196-204. PubMed ID: 31697365
[TBL] [Abstract][Full Text] [Related]
3. Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.
Li D; Sun CL; Kim H; Soto-Perez-de-Celis E; Chung V; Koczywas M; Fakih M; Chao J; Cabrera Chien L; Charles K; Hughes SFDS; Katheria V; Trent M; Roberts E; Jayani R; Moreno J; Kelly C; Sedrak MS; Dale W
JAMA Oncol; 2021 Nov; 7(11):e214158. PubMed ID: 34591080
[TBL] [Abstract][Full Text] [Related]
4. Primary Treatment Modification and Treatment Tolerability Among Older Chemotherapy Recipients With Advanced Cancer.
Mohamed MR; Rich DQ; Seplaki C; Lund JL; Flannery M; Culakova E; Magnuson A; Wells M; Tylock R; Mohile SG
JAMA Netw Open; 2024 Feb; 7(2):e2356106. PubMed ID: 38358742
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Association of Oncologist-Patient Communication With Functional Status and Physical Performance in Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial.
Jensen-Battaglia M; Lei L; Xu H; Kehoe L; Patil A; Loh KP; Ramsdale E; Magnuson A; Kleckner AS; Wildes TM; Lin PJ; Mustian KM; Giri G; Whitehead M; Bearden J; Burnette BL; Geer J; Mohile SG; Dunne RF
JAMA Netw Open; 2022 Mar; 5(3):e223039. PubMed ID: 35302628
[TBL] [Abstract][Full Text] [Related]
7. An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Xu H; Mohamed M; Flannery M; Peppone L; Ramsdale E; Loh KP; Wells M; Jamieson L; Vogel VG; Hall BA; Mustian K; Mohile S; Culakova E
JAMA Netw Open; 2023 Mar; 6(3):e234198. PubMed ID: 36947036
[TBL] [Abstract][Full Text] [Related]
8. Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer.
Culakova E; Mohile SG; Peppone L; Ramsdale E; Mohamed M; Xu H; Wells M; Tylock R; Java J; Loh KP; Magnuson A; Jamieson L; Vogel V; Duberstein PR; Chapman BP; Dale W; Flannery MA
J Clin Oncol; 2023 Feb; 41(4):835-846. PubMed ID: 36356279
[TBL] [Abstract][Full Text] [Related]
9. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.
Presley CJ; Mohamed MR; Culakova E; Flannery M; Vibhakar PH; Hoyd R; Amini A; VanderWalde N; Wong ML; Tsubata Y; Spakowicz DJ; Mohile SG
Front Oncol; 2022; 12():835582. PubMed ID: 35433441
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists.
Gilmore N; Xu H; Kehoe L; Kleckner AS; Moorthi K; Lei L; Mohamed MRS; Loh KP; Culakova E; Flannery M; Ramsdale E; Duberstein PR; Canin B; Kamen C; Giri G; Watson E; Patil A; Onitilo AA; Burnette B; Janelsins M; Mohile SG
Cancer; 2022 Mar; 128(5):1101-1109. PubMed ID: 34762734
[TBL] [Abstract][Full Text] [Related]
11. Multifactorial and multiple component interventions for preventing falls in older people living in the community.
Hopewell S; Adedire O; Copsey BJ; Boniface GJ; Sherrington C; Clemson L; Close JC; Lamb SE
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012221. PubMed ID: 30035305
[TBL] [Abstract][Full Text] [Related]
12. Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial.
Soo WK; King MT; Pope A; Parente P; Dārziņš P; Davis ID
Lancet Healthy Longev; 2022 Sep; 3(9):e617-e627. PubMed ID: 36102776
[TBL] [Abstract][Full Text] [Related]
13. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
[TBL] [Abstract][Full Text] [Related]
14. Communication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment.
Jensen-Battaglia M; Lei L; Xu H; Loh KP; Wells M; Tylock R; Ramsdale E; Kleckner AS; Mustian KM; Dunne RF; Kehoe L; Bearden J; Burnette BL; Whitehead M; Mohile SG; Wildes TM
JCO Oncol Pract; 2022 Oct; 18(10):e1630-e1640. PubMed ID: 35984998
[TBL] [Abstract][Full Text] [Related]
15. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
16. Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer (MAPLE) to communicate ageing-related concerns: J-SUPPORT 2101 study protocol for a multicentre, parallel group, randomised controlled trial.
Matsuoka A; Fujimori M; Narikazu B; Takashima A; Okusaka T; Mori K; Akechi T; Shimazu T; Okizaki A; Miyaji T; Majima Y; Nagashima F; Uchitomi Y
BMJ Open; 2022 Sep; 12(9):e063445. PubMed ID: 36167377
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Geriatric Assessment for community-dwelling, high-risk, frail, older people.
Briggs R; McDonough A; Ellis G; Bennett K; O'Neill D; Robinson D
Cochrane Database Syst Rev; 2022 May; 5(5):CD012705. PubMed ID: 35521829
[TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial).
Cockayne S; Rodgers S; Green L; Fairhurst C; Adamson J; Scantlebury A; Corbacho B; Hewitt CE; Hicks K; Hull R; Keenan AM; Lamb SE; McIntosh C; Menz HB; Redmond A; Richardson Z; Vernon W; Watson J; Torgerson DJ
Health Technol Assess; 2017 Apr; 21(24):1-198. PubMed ID: 28621259
[TBL] [Abstract][Full Text] [Related]
19. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
20. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
